Join us at Health Research Day — June 6th at Canton Waterfront Park, Baltimore!   Learn More →
← Back to all trials
Completed NCT04855903

Executive Functions Computerized Rehabilitation Using Virtual Reality to Improve Activities of Daily Living Post-stroke

Conditions: Stroke

Sex: All
Ages: 18 Years – N/A
Healthy volunteers: No
Phase: NA
Enrollment: 18
Sponsor: University Hospital, Toulouse

Location: Centre de la Tour de Gassies Bruges

Summary

This research aims to evaluate the effects of a cognitive reeducation carried out with the COVIRTUA Cognition software using a virtual environment, on real-life execution of activities of daily living (ADL) for patients with post-stroke dysexecutive disorders. We will assess patients' performances in achieving ADLs by the Goal Attainment Scaling (GAS) throughout the follow-up (3 months), based on the goals set at the beginning of management with each patient.

Eligibility Criteria

Inclusion Criteria: * Vascular brain injury (stroke), in chronic phase (6 months or more after stroke), responsible for dysexecutive syndrome authenticated by the GREFEX/GRECO battery (Executive Function Evaluation Reflection Group) * Men and women over the age of 18 * Presence of a caregiver * Social Security affiliation * Signing free and informed consent following clear and detailed information * Sufficient understanding of the French language to participate in the study Exclusion Criteria: * Pregnant women (clinical examination) * Alcohol and/or narcotics addiction * Major hearing deficit * Major visual deficit * Neurological pathology other than stroke or psychiatric disorder * Unstable epilepsy * Patient undergoing rehabilitation at a liberal therapist targeting executive functions during study time * Patient under safeguard of justice. * Patient simultaneously participating in another research study

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT04855903). StuddyBuddy aggregates publicly available trial information.